USD/JPY outlook: Bears resume through key supports on new Omicron fears
|USD/JPY
Bears resume on Tuesday after a double rejection at pivotal Fibo support at 113.07 (38.2% of 109.11/115.51).
The latest comments from drugmaker Moderna’s CEO that Covid-19 vaccines were unlikely to be as effective against the new Omicron variant as they have been against the Delta version, raised concerns in the market and further boosted the risk aversion.
Fresh extension of the pullback from 115.51 (2021 high, posted on Nov 24) penetrated thick daily cloud (top of the cloud lays at 112.93), and pressure pivot at 112.72 (Nov 9 trough) generating initial bearish signal.
The near-term action is weighed by last Friday’s massive bearish candle, while bearish momentum is gaining pace on daily chart and MA’s forming bear-crosses, adding to negative outlook.
Today’s close below 112.72 would confirm strong bearish signal and open way for test of next key supports at 112.31 (50% retracement) and 111.90 (daily cloud base), violation of which would confirm reversal and open way for a deeper correction.
Res: 112.93; 113.07; 113.89; 114.00.
Sup: 112.31; 112.07; 111.90; 111.56.
Interested in USD/JPY technicals? Check out the key levels
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.